Target intelligence / Profile preview

Histone deacetylase 1 pseudogene 2 (HDAC1P2)

Target: HDAC1P2
Molecular classification: Other (pseudogene)

Overview

HDAC1P2 (Histone deacetylase 1 pseudogene 2) is a human pseudogene related to the functional histone deacetylase 1 (HDAC1) gene[1]. Unlike HDAC1, HDAC1P2 does not produce a functional enzyme and lacks known molecular or biological activity. It is classified as a pseudogene on genomic databases. In scientific and pharmaceutical contexts, HDAC1P2 itself is not considered a therapeutic target, nor does it play a documented role in disease or drug interaction. Misidentification can occur because of similarity in nomenclature to HDAC1, a key enzyme involved in chromatin remodeling and gene repression, which is an actual target for epigenetic therapeutics in oncology and other disease areas[1][7].

Other names: HDAC1P2

Beyond the preview

Go deeper on Histone deacetylase 1 pseudogene 2 (HDAC1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone deacetylase 1 pseudogene 2 (HDAC1P2).

Explore the full profile